Watchlist Price Alert

Clarus Therapeutics Inc. (CRXT)

NASDAQ: CRXT · Real-Time Price · USD

0.05

-0.02 (-27.54%)

At close: Sep 06, 2022, 7:59 PM

Clarus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q2 2020
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Jun 30, 2020
Cash & Equivalents	19.17M	9.14M	26.41M	21.95M	10.28M	408.19K	655.37K	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	58.65M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	58.65M	58.65M	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	-58.65M	n/a	58.65M	62.5K
Receivables	8.71M	8.01M	6.34M	6.93M	6.23M	n/a	n/a	n/a
Inventory	16.8M	14.93M	14.21M	12.48M	9.76M	n/a	n/a	n/a
Other Current Assets	4.2M	4.38M	4.67M	3.89M	1.99M	184.92K	n/a	n/a
Total Current Assets	48.88M	36.45M	51.64M	45.26M	28.25M	593.12K	823.51K	n/a
Property-Plant & Equipment	60K	67K	65K	66K	73K	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	60K	67K	65K	66K	73K	58.65M	58.65M	62.5K
Total Assets	48.94M	36.52M	51.71M	45.32M	28.33M	59.24M	59.47M	62.5K
Account Payables	8.49M	14.06M	13.95M	15.84M	13.46M	83.09K	178.65K	761.00
Deferred Revenue	2.98M	1.98M	1.58M	827K	1.05M	n/a	n/a	n/a
Short-Term Debt	40.51M	38.48M	42.27M	40.34M	51.3M	n/a	n/a	12.5K
Other Current Liabilities	9.83M	11.43M	8.26M	7.37M	11M	612.94K	242.2K	25K
Total Current Liabilities	61.81M	65.95M	66.06M	64.38M	76.81M	696.03K	420.85K	38.26K
Long-Term Debt	n/a	n/a	n/a	n/a	108.93M	n/a	n/a	n/a
Other Long-Term Liabilities	197K	925K	1.57M	6.46M	197.46M	7.56M	18.71M	n/a
Total Long-Term Liabilities	197K	925K	1.57M	6.46M	306.39M	7.56M	18.71M	n/a
Total Liabilities	62M	66.88M	67.63M	70.85M	383.2M	8.26M	19.13M	38.26K
Total Debt	40.51M	38.48M	42.27M	40.34M	160.23M	n/a	n/a	12.5K
Common Stock	5K	2K	2K	2K	3K	45.99M	35.34M	144.00
Retained Earnings	-347.22M	-336.52M	-321.65M	-317.35M	-359.32M	5M	-148.03K	-761
Comprehensive Income	n/a	n/a	n/a	-45.32M	n/a	n/a	n/a	-761
Shareholders Equity	-13.06M	-30.36M	-15.92M	-25.52M	-354.88M	5M	5M	24.24K
Total Investments	n/a	n/a	n/a	n/a	58.65M	58.65M	58.65M	n/a